GenMark Diagnostics Inc (NASDAQ:GNMK)

Data as of Sep 17
 +0.25 / +2.59%
Today’s Change
Today|||52-Week Range
Health Technology
Medical Specialties

Company Description

GenMark Diagnostics, Inc. is a molecular diagnostics company which focuses on developing and commercializing its proprietary eSensor detection technology. The company's eSensor XT-8 system is an automated molecular diagnostic system that enables reference laboratories and hospitals to perform fast, accurate and easy-to-use molecular diagnostic tests. It operates in one business segment, which is the development and commercialization of molecular tests based on its proprietary eSensor detection technology. The company was founded by Jon Faiz Kayyem on February 12, 2010 and is headquartered in Carlsbad, CA.

Contact Information

GenMark Diagnostics, Inc.
5964 La Place Court
Carlsbad California 92008-8829
P:(760) 448-4300
Investor Relations:



Individual stakeholders7.61%
Mutual fund holders66.36%
Other institutional35.48%

Top Executives

Hany MassaranyPresident, Chief Executive Officer & Director
Scott MendelChief Financial Officer
Jon Faiz KayyemSenior VP-Research & Development
Eric J. StierSecretary, Senior Vice President & General Counsel
Michael GleesonSenior VP-North American Commercial Operations

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.